Utah Medical Products Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Utah Medical Products.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment	16.1%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation

May 01

Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?

Mar 26

Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital

Mar 02

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 11

Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain

Jan 27

Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?

Jan 13

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?

Dec 29

Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?

Dec 15

Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?

Nov 30

Utah Medical Products declares $0.285 dividend

Nov 03

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Utah Medical Products no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:UTMD - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2024	49	16	N/A	N/A	N/A
12/31/2023	50	17	22	22	N/A
9/30/2023	51	17	22	23	N/A
6/30/2023	52	17	22	23	N/A
3/31/2023	52	17	22	23	N/A
12/31/2022	52	16	20	21	N/A
9/30/2022	52	16	19	20	N/A
6/30/2022	51	16	20	21	N/A
3/31/2022	50	15	20	21	N/A
12/31/2021	49	15	21	21	N/A
9/30/2021	48	14	22	22	N/A
6/30/2021	46	13	21	21	N/A
3/31/2021	42	11	20	20	N/A
12/31/2020	42	11	19	20	N/A
9/30/2020	42	12	19	20	N/A
6/30/2020	44	13	20	21	N/A
3/31/2020	47	15	18	19	N/A
12/31/2019	47	15	-4	17	N/A
9/30/2019	45	14	-6	16	N/A
6/30/2019	43	17	-7	14	N/A
3/31/2019	42	18	-5	16	N/A
12/31/2018	42	19	16	17	N/A
9/30/2018	42	13	15	17	N/A
6/30/2018	42	10	15	17	N/A
3/31/2018	42	9	15	16	N/A
12/31/2017	41	9	N/A	17	N/A
9/30/2017	40	14	N/A	16	N/A
6/30/2017	40	13	N/A	15	N/A
3/31/2017	39	12	N/A	15	N/A
12/31/2016	39	12	N/A	15	N/A
9/30/2016	40	13	N/A	15	N/A
6/30/2016	40	13	N/A	16	N/A
3/31/2016	40	12	N/A	16	N/A
12/31/2015	40	12	N/A	14	N/A
9/30/2015	41	12	N/A	14	N/A
6/30/2015	41	11	N/A	15	N/A
3/31/2015	41	11	N/A	16	N/A
12/31/2014	41	11	N/A	15	N/A
9/30/2014	41	12	N/A	14	N/A
6/30/2014	40	12	N/A	13	N/A
3/31/2014	40	11	N/A	12	N/A
12/31/2013	40	11	N/A	12	N/A
9/30/2013	40	10	N/A	12	N/A
6/30/2013	41	10	N/A	12	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de UTMD es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de UTMD crezcan más rápidamente que el mercado US

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de UTMD crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de UTMD crezcan más rápidamente que el mercado de US.

Ingresos de alto crecimiento: Insufficient data to determine if UTMD's revenue is forecast to grow faster than 20% per year.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de UTMD se prevé que sea elevada dentro de 3 años.

Utah Medical Products Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Utah Medical Products, Inc. Provides Earnings Guidance for the Second Quarter of 2021

Recent updates

First quarter 2024 earnings released: EPS: US$1.09 (vs US$1.16 in 1Q 2023)

Utah Medical Products, Inc., Annual General Meeting, May 03, 2024

Full year 2023 earnings released: EPS: US$4.58 (vs US$4.53 in FY 2022)

Utah Medical Products: An Attractive, But Speculative, Prospect

Upcoming dividend of US$0.30 per share

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Fourth quarter dividend of US$0.30 announced

Full year 2023 earnings released: EPS: US$4.57 (vs US$4.53 in FY 2022)

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Upcoming dividend of US$0.30 per share at 1.5% yield

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30

Third quarter 2023 earnings released: EPS: US$1.08 (vs US$1.18 in 3Q 2022)

Upcoming dividend of US$0.29 per share at 1.3% yield

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on October 3, 2023

Second quarter 2023 earnings released: EPS: US$1.15 (vs US$1.13 in 2Q 2022)

Chairman notifies of intention to sell stock

Upcoming dividend of US$0.29 per share at 1.2% yield

Independent Director recently sold US$65k worth of stock

Utah Medical Products, Inc. Announces Quarterly Dividend Payable on July 6, 2023

Full year 2022 earnings released

Now 22% undervalued after recent price drop

Upcoming dividend of US$0.29 per share at 1.3% yield

Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on April 4, 2023

Now 21% undervalued

Full year 2022 earnings released: EPS: US$4.52 (vs US$4.06 in FY 2021)

A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)

Upcoming dividend of US$0.29 per share

Investor sentiment improved over the past week

Insufficient new directors

Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on January 4, 2023

Third quarter 2022 earnings released: EPS: US$1.18 (vs US$1.15 in 3Q 2021)

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29

Utah Medical Products declares $0.29 dividend

Second quarter 2022 earnings released: EPS: US$1.12 (vs US$0.94 in 2Q 2021)

Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Independent Director recently sold US$170k worth of stock

Independent Director notifies of intention to sell stock

First quarter 2022 earnings released

Insufficient new directors

Utah Medical Products, Inc., Annual General Meeting, May 06, 2022

Full year 2021 earnings released: EPS: US$4.06 (vs US$2.95 in FY 2020)

Upcoming dividend of US$0.29 per share

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29

Independent Director notifies of intention to sell stock

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Inaugural dividend of US$2.00 per share

Independent Director notifies of intention to sell stock

Independent Director recently sold US$222k worth of stock

Third quarter 2021 earnings released: EPS US$1.15 (vs US$0.81 in 3Q 2020)

Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital

Upcoming dividend of US$0.28 per share

Independent Director recently sold US$176k worth of stock

Independent Director notifies of intention to sell stock

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28

Second quarter 2021 earnings released: EPS US$0.94 (vs US$0.36 in 2Q 2020)

Upcoming dividend of US$0.28 per share

First quarter 2021 earnings released: EPS US$0.83 (vs US$0.85 in 1Q 2020)

Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation

Independent Director notifies of intention to sell stock

Utah Medical Products, Inc. Provides Earnings Guidance for the Second Quarter of 2021

First quarter 2021 earnings released: EPS US$0.83 (vs US$0.85 in 1Q 2020)

Full year 2020 earnings released: EPS US$2.95 (vs US$3.96 in FY 2019)

Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?

New 90-day high: US$92.99

Independent Director recently sold US$90k worth of stock